Today, Boehringer Ingelheim and CBmed GmbH Center for Biomarker Research in Medicine (CBmed) announced a long-term strategic partnership. Jointly the partners will apply translational medicine approaches to accelerate the development of first-in-class medicines to transform the lives of people with cancer and .
/PRNewswire/ BioAI Health, a leader in AI-powered precision medicine, today announced the appointment of Dr. J. Carl Barrett, PhD to its Scientific Advisory.